AMIT TAILOR: Open Payments
NPI 1861431041 · RUTHERFORD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,398 in 49 payments from 11 companies in 2025. Trend: 2023 $1,069 · 2024 $1,131 · 2025 $1,398
Food & beverage: $1,398
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $375 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 19 | $271 |
| ABBVIE INC. | 6 | $189 |
| Xeris Pharmaceuticals, Inc. | 6 | $163 |
| Exact Sciences Corporation | 2 | $129 |
| AstraZeneca Pharmaceuticals LP | 1 | $125 |
| Almatica Pharma LLC | 4 | $63 |
| Collegium Pharmaceutical, Inc. | 2 | $33 |
| Smith+Nephew, Inc. | 1 | $20 |
| PFIZER INC. | 1 | $17 |
Products named: JARDIANCE, XIFAXAN, GVOKE HYPOPEN, UBRELVY, FASENRA, The Cologuard Plus Collection Kit, LOREEV XR, QULIPTA.
Industry payments across NJ — which companies pay providers there.
